We read enthusiastically the article by Nadales et al. that aims to validate and modify improving the predictive capacity of a prognostic score used in transplanted patients with carbapenem- producing enterobacterales bloodstream infection (CPE-BSI) with the new variables (CMV disease status, lymphopenia, no source control, inappropriate empirical therapy and interaction old score with CMV disease status in 30 days before the bacteremia).

中文翻译：

---

CMV 值得进一步的进化和生物学观点。

我们热情地阅读了 Nadales 等人的文章。旨在通过新变量（CMV 疾病状态、淋巴细胞减少、无源头控制、不适当的经验治疗和相互作用）验证和修改用于产碳青霉烯类肠杆菌血流感染 (CPE-BSI) 移植患者的预后评分预测能力的改进菌血症前 30 天内 CMV 疾病状态的旧评分）。